Health and health care; personal characteristics, 2014-2021
Characteristics persons | Margins | Periods | Chronic disorders Disorders in the last 12 months Stroke, cerebral haemorrhage/infarction (%) | Chronic disorders Disorders in the last 12 months Myocardial infarction (%) | Chronic disorders Disorders in the last 12 months Heart condition (%) | Chronic disorders Chronic disorders, ever had Stroke, cerebral haemorrhage/infarction (%) | Chronic disorders Chronic disorders, ever had Myocardial infarction (%) | SF-12 health measure, age 12 or older Separate items Downhearted and blue Constantly (%) | SF-12 health measure, age 12 or older Separate items Downhearted and blue Mostly (%) | SF-12 health measure, age 12 or older Separate items Downhearted and blue Often (%) | SF-12 health measure, age 12 or older Separate items Downhearted and blue Sometimes (%) | SF-12 health measure, age 12 or older Separate items Downhearted and blue Rarely (%) | SF-12 health measure, age 12 or older Separate items Downhearted and blue Never (%) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Value | 2014 | 0.3 | 0.4 | 1.8 | 2.9 | 3.2 | . | . | . | . | . | . |
Total | Value | 2015 | 0.4 | 0.4 | 2.0 | 3.2 | 2.9 | . | . | . | . | . | . |
Total | Value | 2016 | 0.5 | 0.4 | 2.1 | 3.3 | 3.2 | . | . | . | . | . | . |
Total | Value | 2017 | 0.4 | 0.3 | 1.9 | 2.8 | 3.1 | . | . | . | . | . | . |
Total | Value | 2018 | 0.5 | 0.3 | 2.7 | 3.2 | 2.8 | . | . | . | . | . | . |
Total | Value | 2019 | 0.6 | 0.4 | 2.5 | 3.4 | 3.3 | . | . | . | . | . | . |
Total | Value | 2020 | 0.4 | 0.3 | 2.6 | 3.0 | 3.1 | 1.1 | 1.7 | 4.8 | 20.1 | 29.6 | 42.7 |
Total | Value | 2021 | 0.3 | 0.3 | 2.2 | 2.8 | 2.7 | 1.1 | 2.7 | 5.5 | 21.9 | 30.0 | 38.9 |
Total | Lower bound 95% confidence interval | 2014 | 0.2 | 0.3 | 1.6 | 2.6 | 2.8 | . | . | . | . | . | . |
Total | Lower bound 95% confidence interval | 2015 | 0.3 | 0.3 | 1.7 | 2.9 | 2.6 | . | . | . | . | . | . |
Total | Lower bound 95% confidence interval | 2016 | 0.4 | 0.2 | 1.8 | 2.9 | 2.8 | . | . | . | . | . | . |
Total | Lower bound 95% confidence interval | 2017 | 0.3 | 0.2 | 1.6 | 2.4 | 2.8 | . | . | . | . | . | . |
Total | Lower bound 95% confidence interval | 2018 | 0.3 | 0.2 | 2.3 | 2.8 | 2.5 | . | . | . | . | . | . |
Total | Lower bound 95% confidence interval | 2019 | 0.4 | 0.3 | 2.1 | 3.0 | 2.9 | . | . | . | . | . | . |
Total | Lower bound 95% confidence interval | 2020 | 0.3 | 0.1 | 2.3 | 2.6 | 2.7 | 0.9 | 1.4 | 4.3 | 19.2 | 28.5 | 41.6 |
Total | Lower bound 95% confidence interval | 2021 | 0.2 | 0.2 | 1.9 | 2.4 | 2.4 | 0.9 | 2.3 | 4.9 | 20.9 | 28.9 | 37.7 |
Total | Upper bound 95% confidence interval | 2014 | 0.5 | 0.5 | 2.1 | 3.3 | 3.5 | . | . | . | . | . | . |
Total | Upper bound 95% confidence interval | 2015 | 0.5 | 0.5 | 2.3 | 3.6 | 3.3 | . | . | . | . | . | . |
Total | Upper bound 95% confidence interval | 2016 | 0.7 | 0.5 | 2.4 | 3.6 | 3.6 | . | . | . | . | . | . |
Total | Upper bound 95% confidence interval | 2017 | 0.5 | 0.4 | 2.1 | 3.1 | 3.5 | . | . | . | . | . | . |
Total | Upper bound 95% confidence interval | 2018 | 0.6 | 0.5 | 3.0 | 3.6 | 3.2 | . | . | . | . | . | . |
Total | Upper bound 95% confidence interval | 2019 | 0.7 | 0.6 | 2.8 | 3.8 | 3.7 | . | . | . | . | . | . |
Total | Upper bound 95% confidence interval | 2020 | 0.6 | 0.4 | 3.0 | 3.4 | 3.5 | 1.4 | 2.0 | 5.3 | 21.0 | 30.6 | 43.8 |
Total | Upper bound 95% confidence interval | 2021 | 0.5 | 0.4 | 2.6 | 3.2 | 3.1 | 1.5 | 3.1 | 6.1 | 23.0 | 31.1 | 40.1 |
Sex: Male | Value | 2014 | 0.3 | 0.4 | 2.1 | 2.9 | 4.2 | . | . | . | . | . | . |
Sex: Male | Value | 2015 | 0.3 | 0.6 | 1.9 | 3.4 | 4.4 | . | . | . | . | . | . |
Sex: Male | Value | 2016 | 0.6 | 0.4 | 2.1 | 3.6 | 4.8 | . | . | . | . | . | . |
Sex: Male | Value | 2017 | 0.4 | 0.3 | 2.1 | 3.0 | 4.8 | . | . | . | . | . | . |
Sex: Male | Value | 2018 | 0.6 | 0.5 | 2.4 | 3.3 | 4.1 | . | . | . | . | . | . |
Sex: Male | Value | 2019 | 0.5 | 0.5 | 2.3 | 3.7 | 4.7 | . | . | . | . | . | . |
Sex: Male | Value | 2020 | 0.6 | 0.3 | 2.8 | 3.1 | 4.3 | 1.0 | 1.8 | 3.9 | 17.5 | 28.6 | 47.3 |
Sex: Male | Value | 2021 | 0.4 | 0.3 | 2.6 | 2.8 | 4.1 | 0.9 | 2.7 | 4.3 | 18.9 | 29.3 | 43.8 |
Sex: Male | Lower bound 95% confidence interval | 2014 | 0.1 | 0.2 | 1.6 | 2.4 | 3.6 | . | . | . | . | . | . |
Sex: Male | Lower bound 95% confidence interval | 2015 | 0.2 | 0.4 | 1.5 | 2.9 | 3.7 | . | . | . | . | . | . |
Sex: Male | Lower bound 95% confidence interval | 2016 | 0.4 | 0.2 | 1.6 | 3.0 | 4.1 | . | . | . | . | . | . |
Sex: Male | Lower bound 95% confidence interval | 2017 | 0.2 | 0.2 | 1.7 | 2.5 | 4.1 | . | . | . | . | . | . |
Sex: Male | Lower bound 95% confidence interval | 2018 | 0.4 | 0.3 | 2.0 | 2.8 | 3.6 | . | . | . | . | . | . |
Sex: Male | Lower bound 95% confidence interval | 2019 | 0.3 | 0.3 | 1.8 | 3.2 | 4.1 | . | . | . | . | . | . |
Sex: Male | Lower bound 95% confidence interval | 2020 | 0.3 | 0.1 | 2.3 | 2.5 | 3.7 | 0.7 | 1.3 | 3.2 | 16.2 | 27.2 | 45.7 |
Sex: Male | Lower bound 95% confidence interval | 2021 | 0.3 | 0.2 | 2.1 | 2.3 | 3.5 | 0.6 | 2.2 | 3.6 | 17.5 | 27.8 | 42.1 |
Sex: Male | Upper bound 95% confidence interval | 2014 | 0.5 | 0.6 | 2.5 | 3.4 | 4.9 | . | . | . | . | . | . |
Sex: Male | Upper bound 95% confidence interval | 2015 | 0.5 | 0.8 | 2.3 | 4.0 | 5.0 | . | . | . | . | . | . |
Sex: Male | Upper bound 95% confidence interval | 2016 | 0.9 | 0.6 | 2.5 | 4.2 | 5.4 | . | . | . | . | . | . |
Sex: Male | Upper bound 95% confidence interval | 2017 | 0.6 | 0.5 | 2.5 | 3.5 | 5.4 | . | . | . | . | . | . |
Sex: Male | Upper bound 95% confidence interval | 2018 | 0.8 | 0.7 | 2.9 | 3.9 | 4.7 | . | . | . | . | . | . |
Sex: Male | Upper bound 95% confidence interval | 2019 | 0.8 | 0.7 | 2.7 | 4.3 | 5.3 | . | . | . | . | . | . |
Sex: Male | Upper bound 95% confidence interval | 2020 | 0.8 | 0.5 | 3.3 | 3.6 | 5.0 | 1.3 | 2.2 | 4.5 | 18.7 | 30.1 | 48.9 |
Sex: Male | Upper bound 95% confidence interval | 2021 | 0.7 | 0.6 | 3.1 | 3.4 | 4.8 | 1.4 | 3.4 | 5.1 | 20.4 | 30.9 | 45.5 |
Sex: Female | Value | 2014 | 0.4 | 0.4 | 1.6 | 3.0 | 2.1 | . | . | . | . | . | . |
Sex: Female | Value | 2015 | 0.5 | 0.2 | 2.1 | 3.1 | 1.5 | . | . | . | . | . | . |
Sex: Female | Value | 2016 | 0.5 | 0.3 | 2.1 | 2.9 | 1.7 | . | . | . | . | . | . |
Sex: Female | Value | 2017 | 0.4 | 0.2 | 1.6 | 2.6 | 1.5 | . | . | . | . | . | . |
Sex: Female | Value | 2018 | 0.4 | 0.2 | 2.9 | 3.1 | 1.5 | . | . | . | . | . | . |
Sex: Female | Value | 2019 | 0.6 | 0.4 | 2.6 | 3.0 | 1.9 | . | . | . | . | . | . |
Sex: Female | Value | 2020 | 0.3 | 0.2 | 2.5 | 3.0 | 1.9 | 1.2 | 1.7 | 5.7 | 22.6 | 30.5 | 38.3 |
Sex: Female | Value | 2021 | 0.2 | 0.2 | 1.9 | 2.7 | 1.3 | 1.3 | 2.6 | 6.6 | 24.9 | 30.5 | 34.0 |
Sex: Female | Lower bound 95% confidence interval | 2014 | 0.2 | 0.2 | 1.2 | 2.5 | 1.7 | . | . | . | . | . | . |
Sex: Female | Lower bound 95% confidence interval | 2015 | 0.3 | 0.1 | 1.7 | 2.5 | 1.2 | . | . | . | . | . | . |
Sex: Female | Lower bound 95% confidence interval | 2016 | 0.3 | 0.1 | 1.7 | 2.4 | 1.3 | . | . | . | . | . | . |
Sex: Female | Lower bound 95% confidence interval | 2017 | 0.2 | 0.1 | 1.2 | 2.1 | 1.2 | . | . | . | . | . | . |
Sex: Female | Lower bound 95% confidence interval | 2018 | 0.2 | 0.1 | 2.4 | 2.5 | 1.2 | . | . | . | . | . | . |
Sex: Female | Lower bound 95% confidence interval | 2019 | 0.3 | 0.2 | 2.2 | 2.5 | 1.5 | . | . | . | . | . | . |
Sex: Female | Lower bound 95% confidence interval | 2020 | 0.1 | 0.1 | 2.0 | 2.4 | 1.4 | 0.9 | 1.3 | 4.9 | 21.3 | 29.0 | 36.7 |
Sex: Female | Lower bound 95% confidence interval | 2021 | 0.1 | 0.1 | 1.5 | 2.2 | 1.0 | 1.0 | 2.1 | 5.8 | 23.4 | 29.0 | 32.5 |
Sex: Female | Upper bound 95% confidence interval | 2014 | 0.5 | 0.6 | 2.0 | 3.5 | 2.6 | . | . | . | . | . | . |
Sex: Female | Upper bound 95% confidence interval | 2015 | 0.7 | 0.3 | 2.6 | 3.6 | 1.9 | . | . | . | . | . | . |
Sex: Female | Upper bound 95% confidence interval | 2016 | 0.7 | 0.4 | 2.5 | 3.4 | 2.1 | . | . | . | . | . | . |
Sex: Female | Upper bound 95% confidence interval | 2017 | 0.6 | 0.3 | 2.0 | 3.0 | 1.9 | . | . | . | . | . | . |
Sex: Female | Upper bound 95% confidence interval | 2018 | 0.6 | 0.3 | 3.4 | 3.6 | 1.9 | . | . | . | . | . | . |
Sex: Female | Upper bound 95% confidence interval | 2019 | 0.8 | 0.6 | 3.1 | 3.5 | 2.3 | . | . | . | . | . | . |
Sex: Female | Upper bound 95% confidence interval | 2020 | 0.5 | 0.4 | 3.0 | 3.5 | 2.3 | 1.6 | 2.1 | 6.4 | 24.0 | 31.9 | 39.8 |
Sex: Female | Upper bound 95% confidence interval | 2021 | 0.5 | 0.5 | 2.4 | 3.3 | 1.8 | 1.9 | 3.3 | 7.6 | 26.4 | 32.1 | 35.7 |
Age: 0 to 3 years | Value | 2014 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2015 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2016 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2017 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2018 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2019 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2020 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Value | 2021 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower bound 95% confidence interval | 2014 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower bound 95% confidence interval | 2015 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower bound 95% confidence interval | 2016 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower bound 95% confidence interval | 2017 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower bound 95% confidence interval | 2018 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower bound 95% confidence interval | 2019 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower bound 95% confidence interval | 2020 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Lower bound 95% confidence interval | 2021 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper bound 95% confidence interval | 2014 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper bound 95% confidence interval | 2015 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper bound 95% confidence interval | 2016 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper bound 95% confidence interval | 2017 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper bound 95% confidence interval | 2018 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper bound 95% confidence interval | 2019 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper bound 95% confidence interval | 2020 | . | . | . | . | . | . | . | . | . | . | . |
Age: 0 to 3 years | Upper bound 95% confidence interval | 2021 | . | . | . | . | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2014 | . | . | . | . | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2015 | . | . | . | . | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2016 | . | . | . | . | . | . | . | . | . | . | . |
Age: 4 to 11 years | Value | 2017 | . | . | . | . | . | . | . | . | . | . | . |
Source: CBS. |
Dataset is not available.
This table contains data on the perceived state of health and on contacts with providers of medical care of the Dutch population in private households. These data can be grouped by several personal characteristics.
Data available for 2014-2021
Status of the data: final.
Changes as of July 31, 2023:
None, the table has been discontinued.
When will new data be published?
Not applicable. This table has been replaced, see paragraph 3 for a link to the new table.
Description topics
- Chronic disorders
- All respondents are asked: ꞌDo you /Does your child have one or more chronic disorders?ꞌ Chronic means (in anticipation) 6 months or longer. Next, 23 disorders and a remainder category 'other disorders' are presented and persons are asked if they had this disorder during the last 12 months. Persons are asked after 3 of these disorders if they ever suffered from it. Besides (more elaborately) is asked after diabetes. Most questions on specific chronic disorders are being asked to persons of all ages. Questions on disorders that do not occur amongst youngsters are posed to persons of 12 years or older.
- Disorders in the last 12 months
- Chronic diseases/disorders in the last 12 months. Respondents may currently suffer from the disease/disorder or have suffered from it in the last 12 months.
- Stroke, cerebral haemorrhage/infarction
- Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever suffered from a stroke, cerebral haemorrhage or cerebral infarction?ꞌ And ꞌyesꞌ to the question: ꞌDid you have this in the last 12 months?'
- Myocardial infarction
- Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever had a myocardial infarction?ꞌ And ꞌyesꞌ to the question: ꞌDid you have this in the last 12 months?'
- Heart condition
- Percentage of persons aged 12 years and over who answered ꞌyesꞌ to the question: ꞌHave you ever suffered from any other serious heart condition in the last 12 months, such as heart failure or angina pectoris? As of 2018, the question has been changed to: ‘Do you currently have any other serious heart condition, such as heart failure or angina pectoris, or have you had this in the past 12 months?’
- Chronic disorders, ever had
- This concerns 3 chronic disorders/diseases respondents have ever suffered from.
- Stroke, cerebral haemorrhage/infarction
- Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever had a stroke, cerebral haemorrhage or cerebral infarction?'
- Myocardial infarction
- Percentage of persons of 12 years or older who answered ꞌyesꞌ to the question: ꞌHave you ever had a myocardial infarction?'
- SF-12 health measure, age 12 or older
- The 'Short Format 12' or SF-12 questionnaire is a selection of 12 questions from the SF-36 (Ware et al., 1995 *). The SF-12 is a widely used international standard of a generic health measure. The SF-12 measures eight health aspects, namely physical functioning, role limitations due to physical health problems, physical pain, general health, vitality (energy / fatigue), social functioning, role limitations due to emotional problems and mental health. Based on the 12 questions, two partial scales can be calculated; a summary measure for physical health (norm score physical) and a summary measure for psychological health (norm score psychological).
These norm scores are calculated for people aged 12 or older.
*Ware J.E., Kosinski M., Keller S.D. SF-12: How to score the SF-12 Physical and Mental Health Summary Scales. Boston, MA: The Health Institute, New England Medical Center, Second Edition, 1995.- Separate items
- Downhearted and blue
- Respondents aged 12 or older were asked how they have felt in the past 4 weeks:
Would you like to answer each question that best reflects how you have felt?
Did you feel downhearted and blue
1. Constantly
2. Mostly
3. Often
4. Sometimes
5. Rarely
6. Never- Constantly
- Percentage of people 12 years of age or older who ‘constantly’ answer the question ‘Did you feel downhearted and blue?’
- Mostly
- Percentage of people 12 years of age or older who ‘mostly’ answer the question ‘Did you feel downhearted and blue?’
- Often
- Percentage of people 12 years of age or older who ‘often’ answer the question ‘Did you feel downhearted and blue?’
- Sometimes
- Percentage of people 12 years of age or older who ‘sometimes’ answer the question ‘Did you feel downhearted and blue?’
- Rarely
- Percentage of people 12 years of age or older who ‘rarely’ answer the question ‘Did you feel downhearted and blue?’
- Never
- Percentage of people 12 years of age or older who ‘never’ answer the question ‘Did you feel downhearted and blue?’